| 000 | 01861 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515164430.0 | ||
| 264 | 0 | _c20090709 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1523-6838 | ||
| 024 | 7 |
_a10.1053/j.ajkd.2008.11.032 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aScharpé, Johan | |
| 245 | 0 | 0 |
_aImmunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial. _h[electronic resource] |
| 260 |
_bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _cJul 2009 |
||
| 300 |
_a77-85 p. _bdigital |
||
| 500 | _aPublication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFerritins _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfluenza Vaccines _xadverse effects |
| 650 | 0 | 4 |
_aInfluenza, Human _xprevention & control |
| 650 | 0 | 4 |
_aKidney Diseases _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrthomyxoviridae _ximmunology |
| 650 | 0 | 4 | _aOutcome Assessment, Health Care |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 | _aRenal Dialysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPeetermans, Willy E | |
| 700 | 1 | _aVanwalleghem, Johan | |
| 700 | 1 | _aMaes, Bart | |
| 700 | 1 | _aBammens, Bert | |
| 700 | 1 | _aClaes, Kathleen | |
| 700 | 1 | _aOsterhaus, André D | |
| 700 | 1 | _aVanrenterghem, Yves | |
| 700 | 1 | _aEvenepoel, Pieter | |
| 773 | 0 |
_tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _gvol. 54 _gno. 1 _gp. 77-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/j.ajkd.2008.11.032 _zAvailable from publisher's website |
| 999 |
_c18774721 _d18774721 |
||